Plain-English translation of NCT07383311 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether spermidine, a natural compound, can help improve sleep quality and how your brain consolidates memories during sleep in older adults who are experiencing early cognitive changes. Researchers know that poor sleep is connected to cognitive decline and dementia, so this trial is exploring whether improving sleep with this supplement might help slow cognitive changes. You would take the medication daily for 12 weeks while researchers measure your sleep patterns and memory.
As people age, some experience early cognitive changes that can eventually lead to dementia. Poor sleep is increasingly recognized as a risk factor for these changes. This trial exists because researchers believe that this medication might improve sleep quality in ways that support memory and brain health, potentially helping to slow or prevent further cognitive decline.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would visit the research center for an initial overnight sleep study where researchers measure your brain activity during sleep using EEG. You would then be randomly assigned to receive either the daily supplement or a placebo (inactive pill) for 12 weeks, with both looking and tasting identical so neither you nor the researchers know which you're taking. After 12 weeks, you would return for a second overnight sleep study to see how the treatment affected your sleep patterns and memory consolidation.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Germany